Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ronald M Sanchez-Avila"'
Autor:
Beatriz Fernández-Vega, Álvaro Fernández-Vega, Carlos Mario Rangel, Javier Nicieza, Eva Villota-Deleu, José A. Vega, Ronald M. Sanchez-Avila
Publikováno v:
Case Reports in Ophthalmology, Vol 7, Iss 1, Pp 154-162 (2016)
Aims: To report a case of wet age-related macular degeneration (wet-AMD) refractory to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy in a patient who showed visual and anatomical improvement and stabilization after starting
Externí odkaz:
https://doaj.org/article/d5117fc4f1b94e5aa4d6e58963821ba6
Autor:
Ronald M Sanchez-Avila, Alvaro I. Ortiz, Carlos M. Rangel, D. Jaramillo, H. Rodriguez, L.C. Escaf, Clara L Varón, P.L. Cárdenas
Publikováno v:
Archivos de la Sociedad Española de Oftalmología (English Edition). 96:242-250
Objective To report the ocular manifestations in patients with leukaemia. Methods This is a retrospective, descriptive and observational study in patients with ocular manifestations of leukaemia. Results A total of 14 eyes were evaluated correspondin
Autor:
Andrea T Hoyos, Juan D Arias, Francisco J Arango, Carlos M. Rangel, Ronald M Sanchez-Avila, M. Margarita Parra
Publikováno v:
Ophthalmic Surgery, Lasers and Imaging Retina. 52:129-137
BACKGROUND AND OBJECTIVE: Neovascularization is a sight-threatening, uncommon complication of posterior uveitis that often goes undetected until persistent clinical findings appear, or in light of treatment failure. This could be attributed to the re
Autor:
Borja de la Sen-Corcuera, Gorka Orive, Ronald M Sanchez-Avila, Eduardo Anitua, Manuel Caro-Magdaleno, Jesús Montero-Iruzubieta, Jesus Merayo-Lloves
Publikováno v:
Clinical Ophthalmology. 14:1619-1627
Purpose The objective was to evaluate the clinical results obtained from the use of immunosafe plasma rich in growth factors (isPRGF) in the treatment of patients with cicatrizing conjunctivitis (CC) who had not responded to the usual therapy. Patien
Autor:
Yanny Perez, Eduardo J. Viteri, Gustavo A. Parra-Serrano, Silvia J. Granados, Juan D Arias, Ronald M Sanchez-Avila, Maria Margarita Parra, Andrea T Hoyos, Ivetteh Gaibor-Santos, Francisco J Arango
Publikováno v:
Therapeutic Advances in Ophthalmology, Vol 13 (2021)
Therapeutic Advances in Ophthalmology
Therapeutic Advances in Ophthalmology
Background: Timely detection of early microvascular changes in patients with prediabetes could help reduce the likelihood of progression of diabetes-related retinal complications. Aim: To determine early microvascular changes in patients with prediab
Autor:
B de la Sen-Corcuera, Gorka Orive, Ronald M Sanchez-Avila, Eduardo Anitua, P Heredia, Jesus Merayo-Lloves, Francisco Muruzabal
Publikováno v:
Expert opinion on biological therapy. 22(1)
Introduction: The use of blood derivatives and especially Plasma rich in growth factors (PRGF), for regenerative purposes has been a common trend along the last decades in the field of oral surgery, dermatology, orthopedics, and more recently in opht
Autor:
Jesus Merayo-Lloves, Edmar Uribe-Badillo, Carlos Fernández-Vega González, Eduardo Anitua, Borja de la Sen-Corcuera, Francisco Muruzabal, Begoña Baamonde, Luis M. Quirós, Ronald M Sanchez-Avila
Publikováno v:
Vision, Vol 5, Iss 34, p 34 (2021)
Vision
Volume 5
Issue 3
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Vision
Volume 5
Issue 3
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
This study aimed to investigate the use of Plasma Rich in Growth Factors (PRGF) associated with tissue ReGeneraTing Agent (RGTA) drops for the treatment of noninfectious corneal ulcers. RGTA treatment was applied (one drop every two days)
howeve
howeve
Autor:
Álvaro Fernández-Vega Sanz, Ronald M Sanchez-Avila, Alvaro Fernández-Vega González, Jesus Merayo-Lloves
Publikováno v:
International Medical Case Reports Journal. 12:229-233
Purpose To describe the case of a patient with a recurrent large myopic macular hole (MH), who was successfully treated with a plasma rich in growth factors (PRGF) membrane. Case Report A 71-year-old patient presented a myopic MH in his right eye. On
Autor:
Jesus Merayo-Lloves, Francisco Muruzabal, Ronald M Sanchez-Avila, Eduardo Anitua, Gorka Orive
Publikováno v:
European Journal of Ophthalmology. 30:94-103
Purpose: To evaluate the efficacy and safety of plasma rich in growth factors eye drops for the treatment of corneal and ocular surface disorders in patients with graft versus host disease. Methods: This retrospective and longitudinal study included
Autor:
Nancy Jurado, Javier Fernández-Vega Sanz, Belén Alfonso-Bartolozzi, Francisco Muruzabal, José F. Alfonso, Ronald M Sanchez-Avila, Edmar E. Uribe-Badillo, Eduardo Anitua, Jesus Merayo-Lloves, Begoña Baamonde
Publikováno v:
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Medicine
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Medicine
To evaluate the efficacy and safety of plasma rich in growth factors (PRGF) in photorefractive keratectomy (PRK) versus Mitomycin C (MMC). This is a comparative, longitudinal and retrospective case-control study (MMC vs PRGF), in patients with a sphe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e070cb1c37febaad911852dd7ad81acb
http://hdl.handle.net/10651/61003
http://hdl.handle.net/10651/61003